|

Tamoxifen 20 mg Clinical Trials

3 actively recruiting trials

No change since May 2026

Pipeline

Phase 2: 3

Top Sponsors

  • SOLTI Breast Cancer Research Group1
  • Institut Cancerologie de l'Ouest1
  • Fudan University1

Indications

Other3 trials

Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer
Phase 2
Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ
Phase 2
Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.